Imaging

415 Capital is a specialist venture capital firm dedicated to investing in breakthrough and life-saving medical innovation. For over 30 years, the team has empowered exceptional entrepreneurs through capital, expertise, and market access, focusing on large unmet patient needs in chronic diseases, particularly cardio & neurovascular disorders.

Emerging Ventures invests in capital-efficient, Seed-stage, US and Canada-based B2B technology startups using emerging technologies. They focus on execution, strong founding teams, solid traction, and scalable sales processes. They participate in priced seed rounds and occasionally lead rounds.